ASBPW

Aspire Biopharma Holdings, Inc. Warrant
ASBPW

Overview Fund Activity

36 hedge funds and large institutions have $7.27M invested in Aspire Biopharma Holdings, Inc. Warrant in 2022 Q2 according to their latest regulatory filings, with 36 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
36
Holders Change
+36
Holders Change %
–
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
36
Increased
–
Reduced
–
Closed
–
Calls
$2.1M
Puts
–
Net Calls
+$2.1M
Net Calls Change
+$2.1M

Top Buyers

1
Verition Fund Management
Verition Fund Management
Connecticut
$4.4M
2
RCM
Radcliffe Capital Management
Pennsylvania
$1.5M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
$179K
4
SCM
Saba Capital Management
New York
$157K
5
LA
Linden Advisors
New York
$144K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
KL
26
KIM LLC
Kansas
$12K +$12K +100,000 New
WAM
27
Weiss Asset Management
Massachusetts
$8K +$8K +66,199 New
KKRC
28
Kohlberg Kravis Roberts & Co
New York
$6K +$6K +37,500 New
PCM
29
Prelude Capital Management
New York
$4K +$4K +23,571 New
UBS Group
30
UBS Group
Switzerland
$4K +$4K +25,000 New
MTCM
31
Mint Tower Capital Management
Netherlands
$4K +$4K +25,000 New
CM
32
Cohanzick Management
New York
$3K +$3K +18,383 New
CH
33
CVI Holdings
Delaware
$3K +$3K +25,000 New
PI
34
PEAK6 Investments
Illinois
$2.63K +$2.63K +25,000 New
CS
35
Clear Street
New York
$2K +$2K +13,821 New
MF
36
Magnetar Financial
Illinois
$3 +$3 +20,250 New
1
2